Incidental Coronary Calcification Quality Improvement Project
- Conditions
- Coronary Artery DiseaseAtherosclerotic Cardiovascular Disease
- Interventions
- Other: Notification
- Registration Number
- NCT04789278
- Lead Sponsor
- Stanford University
- Brief Summary
This is a multi-center, randomized quality improvement project. At least 200 statin-naïve patients without a history of atherosclerotic cardiovascular disease with incidental coronary artery calcium (CAC) on a prior non-gated chest CT will be enrolled across the Stanford Healthcare System and the Palo Alto Veteran's Affairs Healthcare System. Patients will be randomized in a 1:1 fashion to notification or usual care arms. The primary aim of this project is to estimate the increase in 6-month statin prescription among statin-naïve patients without a history of atherosclerotic cardiovascular disease with incidental CAC on a non-gated chest CT who are randomized to receive notification of their findings vs. usual care.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 173
- Non-gated chest CT between 2014-2019
- The presence of CAC confirmed by manual review by an experienced radiologist
- Stanford affiliated primary care provider or endocrinologist for Stanford healthcare system patients and VA primary care provider for VA patients with at least 1 encounter since 2018
- Current or prior statin or PCSK9 inhibitor therapy
- Prior diagnosis of ASCVD (coronary artery disease, peripheral arterial disease, cerebrovascular disease, coronary/peripheral revascularization)
- Prior coronary imaging (cardiac CT, invasive coronary angiography)
- Dementia
- Metastatic cancer or active cancer undergoing chemotherapy
- History of medical nonadherence
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Notification Notification Patients randomized to notification will receive a message sent by either the electronic health record (EHR) patient portal or postal mail that will inform them of the CAC identified on their previous chest CT. It will provide an overview of CAC, an image of their chest CT, and a recommendation that they discuss this finding with their clinician. These clinicians will be notified of these findings via an earlier EHR message. Any treatment decisions will be made by the patient and their clinician. Patients randomized to notification who are not prescribed a statin medication and do not have a documented discussion regarding statin therapy within three months will be sent a second message at that time. Their primary care providers will receive a second EHR message concurrently.
- Primary Outcome Measures
Name Time Method Rate of Statin Prescription Within 6 months Proportion of patients prescribed a statin
- Secondary Outcome Measures
Name Time Method Number of primary Care Clinical Encounters 6 months Number of Cardiology Referrals 6 months LDL Cholesterol Level 6 months Systolic Blood Pressure 6 months Hemoglobin A1c Level 6 months Statin Intensity 6 months Proportion of patients prescribed a high intensity, intermediate intensity, and low intensity statin
HDL Cholesterol Level 6 months Rate of Aspirin Prescription 6 months Proportion of patients prescribed aspirin
Total Cholesterol Level 6 months Number of Cardiovascular Diagnostic Tests 6 months Triglyceride Level 6 months Number of Hypertension Medications 6 months Body Mass Index 6 months Pooled cohort equations estimated 10-year risk of atherosclerotic cardiovascular disease 6 months
Trial Locations
- Locations (1)
Stanford Hospital & Clinics
🇺🇸Stanford, California, United States